Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

P1.11-001 Economic Impact of Immune Checkpoint Inhibitor Therapy in Brazil and Strategies to Improve Access

2017; Elsevier BV; Volume: 12; Issue: 11 Linguagem: Inglês

10.1016/j.jtho.2017.09.995

1556-1380

Pedro Nazareth Aguiar, Bárbara de Souza Gutierres, Carmélia Maria Noia Barreto, Ramon Andrade de Mello, Hakaru Tadokoro, Auro del Giglio, G. Lopes,

Pharmaceutical Economics and Policy

Immunotherapy was elected by ASCO as the most important advance in Oncology in the last 2 consecutive years. Harnessing the immune system to fight cancer cells has already changed clinical practice. Nevertheless, the cost of immune checkpoint inhibitors is a limitation to their incorporation in several countries, including Brazil. The objective of this study was to estimate the economic impact of immunotherapy and make suggestions in order to improve access for patients who benefit the most from treatment.